What this study is
The goal of this clinical trial is to conduct a randomized controlled trial (RCT) to test the feasibility of two dose- and time-matched pain management programs, delivered via live video, for adults with chronic (lasting at least 3 months) and non-arthritic hip-related pain (HRP). Following pre-determined benchmarks, findings from this trial will be used to assess the feasibility, credibility, and acceptability of both programs (HIPS-1, HIPS-2). In preparation for a future clinical trial powered to test efficacy, we will optimize the protocol for patient recruitment, study protocol, and fidelity materials.
What's being tested
- HIPS-1
Intervention · BEHAVIORAL
HIPS-1 is a 6-session (one 30-minute session per week) mind-body intervention delivered via live-video (i.e., MGB Zoom) by a trained physical therapist (PT). In addition to participating in the HIPS-1 intervention, all participants will attend their prescribed physical therapy with a PT of their choosing. To minimize variability in physical rehabilitation, we will send the PT the Clinical Practice Guidelines, which outline a standard-of-care rehabilitation protocol. Across these six 30-minute sessions, the HIPS-1 intervention aims to teach relaxation and coping skills and provide pain education. After each session, participants will set a physical activity SMART goal for the coming week and complete a weekly check-in survey (i.e., submit weekly home practice, brief pain assessment). All HIPS-1 sessions will be audio-recorded for subsequent interventionist fidelity checks. These recordings will be stored exclusively on MGB-encrypted devices.
- HIPS-2
Intervention · BEHAVIORAL
The HIPS-2 program will be administered via live video (i.e., MGB Zoom) and is time and attention-matched to HIPS-1. As such, HIPS-2 is delivered by a trained PT and consists of 6-sessions (one 30-minute session per week). HIPS-2 contains healthy lifestyle education consistent with public health recommendations, including physical activity, sleep, and nutrition. HIPS-2 has no overlap with HIPS-1. In addition to participating in HIPS-2, all those randomized to this condition will attend their prescribed physical therapy with a PT of their choosing and complete a weekly check-in survey (i.e., brief pain assessment). To minimize variability in physical rehabilitation, we will send the PT the Clinical Practice Guidelines, which outline a standard-of-care rehabilitation protocol. All HIPS-2 sessions will be audio-recorded for subsequent interventionist fidelity checks. These recordings will be stored exclusively on MGB-encrypted devices.
Study details
- Official title
- HIPS Feasibility RCT Testing a Mind-Body Intervention to Improve Recovery for Individuals With Chronic Hip Pain
- Sponsor
- Massachusetts General Hospital
- Conditions
- Hip Pain Chronic · Hip Pain · Physical Medicine and Rehabilitation
- Enrolling
- 50 people
- Starts
- 2026-07-20
- Est. completion
- 2028-06-01
- Design
- Triple-blind, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Presenting with chronic (lasting ≥3 months) hip joint-related pain
- Fluent in English
- Age ≥18yr [If ≥45yr, the physician will confirm no osteoarthritis via X-ray (Kellgren Lawrence [KL] grade 0-1)]
- Score ≥3 for current hip pain on the Pain-VAS
- Psychological risk factor for the maintenance of pain by meeting ≥1 of the criteria listed below:; Score ≥ 20 on the PCS; Score ≤ 40 on the PSEQ; Score ≥ 17 on the TSK-11
- Exhibits sedentariness or dissatisfaction with physical activity by meeting ≥1 of the criteria listed below:; Physically active < 150mins/week according to the IPAQ-SF; Hip pain interferes with the ability to be physically active; Dissatisfaction with the current physical activity level
You can't join if
- Previous surgery on the symptomatic (painful) hip
- Current pain referred from the lower back
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openMassachusetts General Hospital
Boston, Massachusetts, United States
- Kate Jochimsen, PhD, ATC · Contact920-948-7812kjochimsen@mgh.harvard.edu
- Abigail Kapoor · Contact617-724-8431askapoor@mgh.harvard.edu
Recruiting
Study team
Sponsor
Massachusetts General Hospital
Study ID 2026P001097
Principal investigator
Kate Jochimsen, PhD, ATC
Massachusetts General Hospital
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.